Allergy Diagnostics And Therapeutics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Allergy Diagnostics And Therapeutics Market, By Product

7.1.  Allergy Diagnostics And Therapeutics Market, By Product, 2020-2028

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Consumables

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Allergy Diagnostics And Therapeutics Market, By End User

8.1.  Allergy Diagnostics And Therapeutics Market, by End User, 2020-2028

8.1.1.    Diagnostic Laboratories

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Hospitals

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Academic Research Institutes

8.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Allergy Diagnostics And Therapeutics Market, By Allergen Type

9.1.  Allergy Diagnostics And Therapeutics Market, By Allergen Type, 2020-2028

9.1.1.    Food

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Inhaled

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Drug

9.1.3.1.        Market Revenue and Forecast (2016-2028)

9.1.4.    Other

9.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Allergy Diagnostics And Therapeutics Market, By Test

10.1.        Allergy Diagnostics And Therapeutics Market, By Test, 2020-2028

10.1.1.  In vivo Test

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  In vitro Test

10.1.2.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Allergy Diagnostics And Therapeutics Market, By Drug Class

11.1.        Allergy Diagnostics And Therapeutics Market, By Drug Class, 2020-2028

11.1.1.  Antihistamines

11.1.1.1.      Market Revenue and Forecast (2016-2028)

11.1.2.  Decongestants

11.1.2.1.      Market Revenue and Forecast (2016-2028)

11.1.3.  Corticosteroids

11.1.3.1.      Market Revenue and Forecast (2016-2028)

11.1.4.  Mast Cell Stabilizers

11.1.4.1.      Market Revenue and Forecast (2016-2028)

11.1.5.  Leukotriene Inhibitors

11.1.5.1.      Market Revenue and Forecast (2016-2028)

11.1.6.  Nasal Anticholinergics

11.1.6.1.      Market Revenue and Forecast (2016-2028)

11.1.7.  Immunomodulators

11.1.7.1.      Market Revenue and Forecast (2016-2028)

11.1.8.  Autoinjectable Epinephrine

11.1.8.1.      Market Revenue and Forecast (2016-2028)

11.1.9.  Immunotherapy

11.1.9.1.      Market Revenue and Forecast (2016-2028)

Chapter 12.      Global Allergy Diagnostics And Therapeutics  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product (2016-2028)

12.1.2.  Market Revenue and Forecast, by End User (2016-2028)

12.1.3.  Market Revenue and Forecast, By Allergen Type (2016-2028)

12.1.4.  Market Revenue and Forecast, By Test (2016-2028)

12.1.5.  Market Revenue and Forecast, By Drug Class (2016-2028)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.1.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.1.6.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.1.6.4.      Market Revenue and Forecast, By Test (2016-2028)

12.1.6.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.1.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.1.7.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.1.7.4.      Market Revenue and Forecast, By Test (2016-2028)

12.1.7.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product (2016-2028)

12.2.2.  Market Revenue and Forecast, by End User (2016-2028)

12.2.3.  Market Revenue and Forecast, By Allergen Type (2016-2028)

12.2.4.  Market Revenue and Forecast, By Test (2016-2028)

12.2.5.  Market Revenue and Forecast, By Drug Class (2016-2028)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.6.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.2.6.4.      Market Revenue and Forecast, By Test (2016-2028)

12.2.6.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.7.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.2.7.4.      Market Revenue and Forecast, By Test (2016-2028)

12.2.7.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.8.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.8.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.2.8.4.      Market Revenue and Forecast, By Test (2016-2028)

12.2.8.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.9.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.9.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.2.9.4.      Market Revenue and Forecast, By Test (2016-2028)

12.2.9.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product (2016-2028)

12.3.2.  Market Revenue and Forecast, by End User (2016-2028)

12.3.3.  Market Revenue and Forecast, By Allergen Type (2016-2028)

12.3.4.  Market Revenue and Forecast, By Test (2016-2028)

12.3.5.  Market Revenue and Forecast, By Drug Class (2016-2028)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.6.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.3.6.4.      Market Revenue and Forecast, By Test (2016-2028)

12.3.6.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.7.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.3.7.4.      Market Revenue and Forecast, By Test (2016-2028)

12.3.7.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.8.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.8.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.3.8.4.      Market Revenue and Forecast, By Test (2016-2028)

12.3.8.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.9.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.9.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.3.9.4.      Market Revenue and Forecast, By Test (2016-2028)

12.3.9.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product (2016-2028)

12.4.2.  Market Revenue and Forecast, by End User (2016-2028)

12.4.3.  Market Revenue and Forecast, By Allergen Type (2016-2028)

12.4.4.  Market Revenue and Forecast, By Test (2016-2028)

12.4.5.  Market Revenue and Forecast, By Drug Class (2016-2028)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.6.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.4.6.4.      Market Revenue and Forecast, By Test (2016-2028)

12.4.6.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.7.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.4.7.4.      Market Revenue and Forecast, By Test (2016-2028)

12.4.7.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.8.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.8.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.4.8.4.      Market Revenue and Forecast, By Test (2016-2028)

12.4.8.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.9.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.9.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.4.9.4.      Market Revenue and Forecast, By Test (2016-2028)

12.4.9.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product (2016-2028)

12.5.2.  Market Revenue and Forecast, by End User (2016-2028)

12.5.3.  Market Revenue and Forecast, By Allergen Type (2016-2028)

12.5.4.  Market Revenue and Forecast, By Test (2016-2028)

12.5.5.  Market Revenue and Forecast, By Drug Class (2016-2028)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.5.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.5.6.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.5.6.4.      Market Revenue and Forecast, By Test (2016-2028)

12.5.6.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.5.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.5.7.3.      Market Revenue and Forecast, By Allergen Type (2016-2028)

12.5.7.4.      Market Revenue and Forecast, By Test (2016-2028)

12.5.7.5.      Market Revenue and Forecast, By Drug Class (2016-2028)

Chapter 13.  Company Profiles

13.1.              bioMerieux

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Thermo Fisher Scientific

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Danaher Corporation

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Omega Diagnostics

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Hitachi Chemical Diagnostics

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Stallergenes Greer

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Siemens Healthcare

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Lincoln Diagnostics

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Hycor Biomedical

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           HOB Biotech Group

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Alcon Laboratories.

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms